Who needs LH in ovarian stimulation?

Reproductive BioMedicine Online

Volumn 22, Issue S1, 2011, Pages S33-S41

  Alviggi, C ^a   Clarizia, R ^a   Mollo, A ^a   Ranieri, A ^a   De Placido, G ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

assisted reproductive techniques; GnRH antagonists; LH; ovarian stimulation; recombinant gonadotrophins

Indexed keywords

EID: 84874952482     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/S1472-6483(11)60007-2     Document Type: Conference Paper

References (47)

1. C Alviggi, K Pettersson, A Mollo et al. Impaired multiple follicular development in carriers of Trp8Arg and Ile15Thr LL-beta variant undergoing controlled ovarian stimulation Human Reproduction 20 Suppl. 1 2005 i139
2. J Balasch, E Vidal, J Penarrubia et al. Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH Human Reproduction 16 2001 1636 1643
3. I Cédrin-Durnerin, D Grange-Dujardin, A Laffy et al. Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles: a prospective randomized study Human Reproduction 19 2004 1979 1984
4. SC Chappel, C Howles Reevaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process Human Reproduction 6 1991 1206 1212
5. K Chung, L Krey, J Katz et al. Evaluating the role of exogenous luteinizing hormone in poor responders undergoing in vitro fertilization with gonadotropin-releasing hormone antagonists Fertility and Sterility 84 2005 313 318
6. S Daya Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction Fertility and Sterility 77 2002 711 714
7. G De Placido, A Mollo, R Clarizia et al. Gonadotrophin-releasing hormone (GnRH) antagonist plus recombinant luteinizing hormone versus a standard GnRH agonist short protocol in patients at risk for poor ovarian response Fertility and Sterility 85 2006 247 250
8. G De Placido, C Alviggi, A Perino et al. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial Human Reproduction 20 2005 390 396
9. G De Placido, C Alviggi, A Mollo et al. Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperStimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary downregulation Clinical Endocrinology (Oxford) 60 2004 637 643
10. G De Placido, A Mollo, C Alviggi et al. Rescue of IVF cycles by HMG in pituitary down-regulated normogonadotrophic young women characterized by a poor initial response to recombinant FSH Human Reproduction 16 2001 1875 1879
11. G De Placido, C Alviggi, A Mollo et al. Recombinant follicle stimulating hormone is effective in poor responders to highly purified follicle stimulating hormone Human Reproduction 15 2000 17 20
12. P Drakakis, D Loutradis, K Kallianidis et al. Small doses of LH activity are needed early in ovarian stimulation for better quality oocytes in IVF-ET European Journal of Obstetrics and Gynecology and Reproductive Biology 121 2005 77 80
13. GF Erickson, C Wang, AJW Hsueh FSH induction of functional LH receptors in granulosa cells cultured in a chemically defined medium Nature 279 1979 336 338
14. MA Esposito, KT Barnhart, C Coutifaris et al. Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle-stimulating hormone Fertility and Sterility 75 2001 519 524
15. AP Ferraretti, L Gianaroli, MC Magli et al. Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques Fertility and Sterility 82 2004 1521 1526
16. H Fevold Synergysm of follicle stimulating and luteinizing hormones in producing estrogen secretion Endocrinology 28 1941 33 36
17. M Filicori, GE Cognigni, P Pocognoli et al. Current concepts and novel applications of LH activity in ovarian stimulation Trends in Endocrinology and Metabolism 14 2003 267 273
18. M Filicori, GE Cognigni, W Ciampaglia What clinical evidence for an LH ceiling? Human Reproduction 18 2003 1556 1557
19. M Filicori, GE Cognigni, S Taraborrelli et al. Intracytoplasmic sperm injection pregnancy after low-dose human chorionic gonadotrophin alone to support ovarian folliculogenesis Fertility and Sterility 78 2002 414 416
20. R Fleming, F Lloyd, M Herbert et al. Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone Human Reproduction 13 1998 1788 1792
21. Ganirelix Dose-Finding Study Group A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon) Human Reproduction 13 1998 3023 3031
22. G Griesinger, A Schultze-Mosgau, K Dafopoulos et al. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol Human Reproduction 20 2005 200 206
23. SG Hillier, PF Whitelaw, CD Smyth Follicular oestrogen synthesis: the 'two-cell, two-gonadotrophin' model revisited Molecular and Cellular Endocrinology 100 1994 51 54
24. ZH Huang, PE Clayton, G Brady et al. Insulin-like growth factor-I gene expression in human granulosa-lutein cells Journal of Molecular Endocrinology 12 1994 283 291
25. EG Hughes, DM Fedorkow, S Daya et al. The routine use of gonadotrophin-releasing hormone agonists prior to in vitro fertilisation and gamete intrafallopian transfer: a meta-analysis of randomised controlled trials Fertility and Sterility 58 1992 888 896
26. I Huhtaniemi, M Jiang, Nilsson et al. Mutations and polymorphisms in gonadotropin genes Molecular and Cellular Endocrinology 25 1999 89 94
27. P Humaidan, M Bungum, L Bungum et al. Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study Reproductive BioMedicine Online 6 2004 635 643
28. P Humaidan, L Bungum, M Bungum et al. Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation Human Reproduction 17 2002 2016 2021
29. JM Hurwitz, N Santoro Inhibins, activins, and follistatin in the aging female and male Seminars in Reproductive Medicine 22 2004 209 217
30. M Jiang, P Pakarinen, FP Zhscag et al. A common polymorphic allele of the human luteinizing hormone beta-subunit gene: additional mutations and differential function of the promoter sequence Human Molecular Genetics 8 1999 2037 2046
31. EM Kolibianakis, K Zikopoulos, J Schiettecatte et al. Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF Human Reproduction 19 2004 2490 2496
32. JY le Cotonnec, HC Porchet, V Beltrami et al. Clinical pharmacology of recombinant human luteinizing hormone: part I. Pharmacokinetics after intravenous administration to healthy female volunteers and comparison with urinary human luteinizing hormone Fertility and Sterility 69 1998 189 194
33. JY le Cotonnec, HC Porchet, V Beltrami et al. Clinical pharmacology of recombinant human luteinizing hormone: part II. Bioavailability of recombinant human luteinizing hormone assessed with an immunoassay and an in vitro bioassay Fertility and Sterility 69 1998 195 200
34. F Lisi, L Rinaldi, S Fishel et al. Use of recombinant FSH and recombinant LH in multiple follicular stimulation for IVF: a preliminary study Reproductive BioMedicine Online 3 2001 190 194
35. R Marrs, D Meldrum, S Muasher et al. Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment Reproductive BioMedicine Online 8 2004 175 182
36. R Mitchell, S Hollis, C Rothwell, WR Robertson Age related changes in the pituitary-testicular axis in normal men; lower serum testosterone results from decreased bioactive LH drive Clinical Endocrinology 42 1995 501 507
37. MG Ropelato, MC Garcia-Rudaz, C Castro-Fernandez et al. A preponderance of basic luteinizing hormone (LH) isoforms accompanies inappropriate hypersecretion of both basal and pulsatile LH in adolescents with polycystic ovarian syndrome Journal of Clinical Endocrinology and Metabolism 84 1999 4629 4636
38. K Shima, S Kitayama, R Nakano Gonadotropin binding sites in human ovarian follicles and corpora lutea during the menstrual cycle Obstetrics and Gynecology 69 1987 800 806
39. Z Shoham, M Schacter, E Loumaye et al. The luteinizing hormone surge-the final stage in ovulation induction: modern aspects of ovulation triggering Fertility and Sterility 64 1995 237 251
40. ES Sills, DP Levy, M Moomjy et al. A prospective, randomized comparison of ovulation induction using highly purified follicle-stimulating hormone alone and with recombinant human luteinizing hormone in in-vitro fertilization Human Reproduction 14 1999 2230 2235
41. M Van Wely, LG Westergaard, PM Bossuyt et al. Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles Cochrane Database of Systematic Reviews 1 2003 CD003973
42. KK Vihko, E Kujansuu, P Morsky et al. Gonadotropins and gonadotropin receptors during the perimenopause European Journal of Endocrinology 134 1996 357 361
43. LG Westergaard, K Erb, SB Laursen et al. Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a prospective randomized study Fertility and Sterility 76 2001 543 549
44. LG Westergaard, SB Laursen, CY Andersen Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction Human Reproduction 15 2000 1003 1008
45. DS Willis, H Watson, HD Mason et al. Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation Journal of Clinical Endocrinology and Metabolism 83 1998 3984 3991
46. AJ Zeleznik, SG Hillier The role of gonadotropins in the selection of the preovulatory follicle Clinical Obstetrics and Gynecology 27 1984 927 940
47. J Zhou, C Bondy Anatomy of the human ovarian insulin-like growth factor system Biology of Reproduction 48 1993 467 482